Roger A. Goldberg, MD, MBA; David R.P. Almeida, MD, PhD, MBA; Jennifer I. Lim, MD, FARVO

Community Practice Connections™: Novel Therapies for Neovascular Retinal Disease – Expert Analysis of New Key Data

Michael Javaheri, MD; Carolyn Majcher, OD, FAAO, FORS

Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)

Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)

Joseph Mikhael, MD, MEd, FRCPC, FACP; Amrita Krishnan, MD, FACP; Shaji Kumar, MD; Ashley Rosko, MD

Medical Crossfire®: Risk-Adapted Management of Multiple Myeloma—How Do the Experts Do It?

Melissa Johnson, MD; Dara Aisner, MD, PhD; David R. Gandara, MD; Balazs Halmos, MD, MS

Top 10 Oncogenic Drivers in NSCLC for 2024: Where Are We and Where Are We Going?

Karen M. Winkfield, MD, PhD; Narjust Florez, MD, FASCO; Gilberto de Lima Lopes Junior, MD, MBA, FASCO; Coral Olazagasti, MD; Vonetta M. Williams, MD, PhD

Working Group™: Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

Peter Voorhees, MD; Noopur Raje, MD; Saad Z. Usmani, MD, MBA, FACP, FASCO

Broadening Horizons in Newly Diagnosed Multiple Myeloma—Exploring New Combination Approaches and Their Impact

Ticiana Leal, MD; Jennifer W. Carlisle, MD; Nisha Mohindra, MD; Martin Wermke, MD

DLL3 as a Therapeutic Target in SCLC and Beyond: Rationale, Recent Data and Potential for Transformations in Care with T-Cell Engagers

Hanny Al-Samkari, MD; Michele P. Lambert, MD, MSTR; Joseph Shatzel, MD, MCR

Medical Crossfire®: Identifying New Pathways to Better Outcomes in Chronic ITP

Anne Chiang, MD, PhD; Megan E. Daly, MD; Carl M. Gay, MD, PhD; Jacob Sands, MD

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

23rd Annual School of Breast Oncology

Join us at The Ophthalmology Meeting in Orlando this October

EyeCon 2025

2025 International Symposium of Gastrointestinal Oncology (ISGIO) 

3rd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between

Edward S. Kim, MD, MBA; Leah M. Backhus MD, MPH, FACS; Lyudmila A. Bazhenova, MD

Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?

Thierry Facon, MD; Francesca Gay, MD, PhD; Pieter Sonneveld, MD, PhD

New Combination-Based Approaches to NDMM: What Do the Data, the Experts, and Patients Say?

Milan J. Anadkat, MD; Arash Mostaghimi, MD, MPA, MPH

Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis

Christopher D. Riemann, MD; Michael Javaheri, MD; Mary Beth Yackey, OD

Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (CME Track)

Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (COPE Track)

Reshma Jagsi, MD, DPhil; Kevin Kalinsky, MD, MS; Hope S. Rugo, MD, FASCO; Alastair Thompson, MD, MBChB, BSc (Hons), FRCS (Ed), FACS; Debu Tripathy, MD


Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

9th Annual School of Nursing Oncology™

Kristina M. Deligiannidis, MD; Marlene P. Freeman, MD

Expert Perspectives in the Recognition and Management of Postpartum Depression

Leonard G. Gomella, MD, FACS; Daniel P. Petrylak, MD; Maha Hussain, MD, FACP, FASCO; Wenxin (Vincent) Xu, MD

Community Practice Connections™: 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Retina Specialists: Join us in Long Beach

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

9th Annual Live Medical Crossfire®: Hematologic Malignancies

26th Annual International Lung Cancer Congress®

BURST CME™: How Are Emerging Biomarkers and Testing Methodologies Shaping Personalized Medicine in NSCLC?

BURST CME™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in Metastatic CRC

Claudine Isaacs, MD; Kayla S. Freeman, DNP, APRN, FNP-C; Abbey Kaler, MS, APRN, FNP-C, PhD(c)

Show Me Your Care Plan! Managing Breast Cancer Patients Under Current Data for Immuno- and Targeted Therapies, CDK4/6i, ADCs and Beyond

Stephen V. Liu, MD; Benjamin P. Levy, MD, FASCO; Laura Macke, MS, BSN, FNP-C, AOCNP; Michelle M. Turner, MSN, CRNP

Navigating Current State-of-the Art NSCLC Patient Care From the Front Lines: Essentials for Oncology Nurses Today and Tomorrow

Taha Bat, MD; Shannon Carroll, MSN, CRNP; Kimberly Smith, MSN, AGNP-C

Medical Crossfire®: Onco-Nurses Exchange Best Practices on PNH Treatment and Symptom Management Along the Patient Care Journey

Gabriela Hobbs, MD; Jenna Moran, MSN, FNP-BC; Michelle Tackett, PA-C

Show Me Your Care Plan™: How Can Onco-Nurses Improve Patient Care in CML Across the Treatment Continuum?

24th Annual International Congress on the Future of Breast Cancer® West

Wendy W. Lee, MD; Chris R. Alabiad, MD; Katherine Rachon, OD, FAAO, Dipl ABO; Ana Carolina Victoria, MD, FACS

(CME Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease

Southern California Psychiatry Conference

(COPE Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease

24th Annual International Congress on the Future of Breast Cancer® East

Revolutionizing Atopic Dermatitis (RAD) Conference 2025

Medical Crossfire™: Integrating Recent Evidence into the Treatment of Newly Diagnosed Multiple Myeloma

Practical Approaches to Modern Dry Eye Treatment and Management

Go To PER in Chicago

Collaborative Care Symposium

Melissa Johnson, MD; Edward Garon, MD, MS; Solange Peters, MD, PhD; Ignacio I. Wistuba, MD

Revolutionizing Early-Stage NSCLC Treatment: Pathologists’ Key Insights Into Predicting Pathologic Responses to Immunotherapies

Susan F. Slovin, MD, PhD; Michael Lai, ARNP; Nerina T. McDonald, PA-C

Show Me Your Care Plan!™: Nurses on the Forefront of Patient Care, Communication, and Education in Prostate Cancer

19th Annual Controversies in Modern Eye Care

16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

Exploring the Benefits and Risks of AI in Oncology

New Combination-Based Approaches to Newly Diagnosed MM: What Do the Data, the Experts, and Patients Say?

Robert S. Busch, MD, FACE; Javier Morales, MD, FACP, FACE; Lucia M. Novak, MSN, ANP-BC, BC-ADM

A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology

Inas Aboobakar, MD; Janelle Davison, OD; Eydie G. Miller-Ellis, MD

Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)

Julie R. Brahmer, MD, MSc, FASCO; Bruna Pellini, MD; Jaime Laurel Schneider, MD, PhD; Mark A. Socinski, MD

Community Practice Connection™: 21st Annual Winter Lung Cancer Conference®

Talia Kaden, MD; Avni Finn, MD, MBA; Cecelia Koetting, OD, FAAO, DipABO; Geeta Lalwani, MD

Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)

Andre H. Goy, MD; Marco L. Davila, MD, PhD; Ajay K. Nooka, MD, MPH, FACP

Community Practice Connections™: Pre-Conference Workshop on Immune Cell-Based Therapy

Murtaza Adam, MD; Laxmi V. Devisetty, MD; Hong-Uyen Hua, MD; Sherrol A. Reynolds, OD

Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (CME Track)

Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (COPE Track)

Kevin Kalinsky, MD, MS; Komal Jhaveri, MD, FACP; Reshma L. Mahtani, DO; Kelly McCann, MD, PhD

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

Komal Jhaveri, MD, FACP; Sunil S. Badve, MD, FRCPath; Paolo Tarantino, MD

Community Practice Connection™:  How We Do It™: Defining HER2 Low on Your Pathology Reports to Make Informed Decisions in Breast Cancer Treatment

Joyce O’Shaughnessy, MD; Michael Alvarado, MD; Heather McArthur, MD, MPH; Debu Tripathy, MD

Community Practice Connection™: Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

Omid Hamid, MD; Jason Luke, MD; Tara Mitchell, MD; Sapna Patel, MD; Jeffrey S. Weber, MD, PhD 

Community Practice Connections™: 20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies

E. Gabriela Chiorean, MD, FASCO; John L. Marshall, MD; Diana L. Hanna, MD; Syma Iqbal, MD; Heloisa P. Soares, MD, PhD Associate Professor 

  Community Practice Connections™: 9th Annual School of Gastrointestinal Oncology®

Jorge E. Cortes, MD; Ann LaCasce, MD, MMSc; Sagar Lonial, MD, FACP; Jennifer Woyach, MD


Community Practice Connections: 28th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

Zaina Al-Mohtaseb, MD; Himani Goyal, MD; Jacqueline Theis, OD, FAAO;  Angela Y. Zhu, MD

Community Practice Connections™: Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (CME Track)

Community Practice Connections™: Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (COPE Track)

W. Lloyd Clark, MD; Roger A. Goldberg, MD, MBA

Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (Cope Credit)

Sruthi Arepalli, MD; Majda Hadziahmetovic, MD; Carolyn Majcher, OD, FAAO, FORS

Surv.AI Says: Real-World Insights Into Patient Burden & Evolving Strategies in nAMD and DME (CME Credit)

Surv.AI Says: Real-World Insights into Patient Burden & Evolving Strategies in nAMD and DME (COPE Credit)

Javier Morales, MD, FACP, FACE; Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; E. Seth Kramer, DO, MPH


Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age

Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)

Jade Coats, OD; Cecelia Koetting OD, FAAO, DipABO; Justin Schweitzer, OD, FAAO

Community Practice Connections™: Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)

Community Practice Connections™: Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)

Neeraj Agarwal, MD, FASCO; Himisha Beltran, MD; Maha Hussain, MD, FACP, FASCO

Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2

Yasha Modi, MD; Carolyn Majcher, OD, FAAO, FORS

(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments

Rahul Gosain, MD, MBA; Rohit Gosain, MD; Ghassan Abou-Alfa, MD, MBA

Addressing Unmet Needs in HER2+ Metastatic BTC

Virginia Kaklamani, MD, DSc; Kate Baxstrom, MD

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

Tiffany A. Traina, MD, FASCO; Arielle L. Heeke, MD

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Leonard G. Gomella, MD, FACS; Maha Hussain, MD, FACP, FASCO; Daniel P. Petrylak, MD

18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Patrick I. Borgen, MD; Joshua Feinberg, MD; Gary Schwartz, MD, FASA

Updates and Innovations in Nonopioid Pain Management Strategies for Breast Cancer Patients Postsurgical Intervention

Allison Betof Warner, MD, PhD; Sajjad A. Bhatti, MD

Community Oncology Connections™: Contextualizing Novel Immunotherapy for Advanced Melanoma – How Do TIL Therapies Fit into Practice? | Arkansas

Community Oncology Connections™: Contextualizing Novel Immunotherapy for Advanced Melanoma – How Do TIL Therapies Fit into Practice? | Wisconsin

Tiffany A. Traina, MD, FASCO; Ashley Frith, MD

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Indiana

Marina Chiara Garassino, MD; Sarah Goldberg, MD, MPH; Biagio Ricciuti, MD, PhD

Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies

Lauren Averett Byers, MD; Percy Lee, MD, FASTRO; Erminia Massarelli, MD, PhD, MS

(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Shamik Bhattacharyya, MD, MS, FAAN; Mirla Avila, MD; Dean Wingerchuk, MD

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

Marc R. Bloomenstein, OD, FAAO; Cory J. Lappin, OD, MS, FAAO; Selina R. McGee, OD, FAAO

Rachel Simpson, MD; James Murphy, MD; Mary Qiu, MD; Jessica Steen, OD, FAAO

(CME Track) Visionary Approaches: Rethinking Therapeutic and Interventional Glaucoma Management

(CME Track) Expanding Horizons in Toric IOLs: Translating Technological Advances Into Improved Patient Outcomes

Adrienne W. Scott, MD, FASRS; Justine Cheng, MD; Hong-Uyen Hua, MD; Sherrol A. Reynolds OD, FAAO, FNAP

(CME Track) Patient-Centered Treatment Strategies in the Management of nAMD and DME

Sara T. Wester, MD, FACS; Cecelia Koetting, OD; Sophie Liao, MD; Jennifer Murdock, MD

(CME Track) The TED Perspective: A Multidisciplinary Approach to Thyroid Eye Care

David S. Liao, MD, PhD; Chang Sup Lee, MD; Douglas Matsunaga, MD; Daniel Su, MD

(CME Track) Revolutionizing nAMD and DME Management: Collaborative Strategies in the Age of Durable Treatments

Laxmi V. Devisetty, MD; Rodney P. Coe, MD, MS; Majda Hadziahmetovic, MD; Xiao Yi (Ellie) Zhou, MD

Continuing Education